Developer docs
API playgroundTry for free, no card

Search company profiles

anchor diagnostics

Full company profile

uuid02m3ht1

Namestring
anchor diagnostics
Legal namestring
ANCHOR Diagnostics GmbH
Company typeenum
Private
Founded yearint
2015
Descriptiontext

ANCHOR Diagnostics GmbH is a Hamburg, Germany-based molecular diagnostics company founded in 2015 that develops, manufactures, and distributes high-speed real-time PCR (polymerase chain reaction) test systems for infectious disease detection. The company's integrated workflow combines the ANCHOR BEAD 32 sample purification instrument and SpeedPURE reagents with a broad portfolio of CE-IVD-marked and RUO PCR kits covering herpesviruses (CMV, EBV, HSV 1/2, VZV, HHV-6/7/8), polyomaviruses (BK/JC), respiratory pathogens (Influenza A/B, SARS-CoV-2, viral respiratory multiplex), gastrointestinal pathogens (Norovirus, C. difficile), Monkeypox/Orthopoxvirus, and the emerging OROV arbovirus. The core technical proposition is a sub-60-minute sample-to-result workflow with PCR run times as short as 30 minutes, enabled by proprietary chemistry using distinguishable fluorescent dyes for parallel multi-target detection, integrated internal controls, and harmonized temperature profiles across all kits that allow seamless operation on standard laboratory cycler platforms (e.g., Roche MagNA Pure 96, cobas z480).

The company operates as a private GmbH with 11–50 employees and holds ISO 13485 certification for its quality management system. It generates revenue primarily through the sale of PCR kits (typically sold in 100-reaction kit formats) at quote-based unit pricing, supplemented by contract development services for custom molecular diagnostic solutions. The go-to-market model relies on a growing network of regional distribution partners across Europe (Italy, Poland, Nordics, UK & Ireland, Czech Republic, Greece, Benelux), Latin America (Colombia), the Middle East (Saudi Arabia), and Türkiye, complemented by direct quote handling via the company website and selective field sales engagement. Marketing efforts emphasize scientific credibility through LinkedIn, downloadable whitepapers, technical documentation, and participation in major industry conferences such as ESCMID.

ANCHOR Diagnostics' target customers are clinical diagnostic laboratories, research laboratories, and healthcare providers requiring rapid, reliable molecular testing for infectious disease management. The BSFZ Seal for Research and Development from the German Federal Ministry of Education and Research (awarded September 2025) and the November 2025 cross-laboratory validation study with MVZ Labor 28 (Berlin) reinforce the company's positioning on analytical rigor and scientific validation. The company is led by Thomas Grewing (legal representative) and Dr. Tobias Ruckes (Head of Sales & Marketing), with Ellen Knabbe serving as a Scientist contributing to product development. No external institutional funding rounds or acquisition activity are recorded in the available data, suggesting organic, founder-led growth.

Short descriptiontext

ANCHOR Diagnostics GmbH is a Hamburg, Germany-based molecular diagnostics company developing high-speed PCR test kits and extraction reagents for infectious disease detection, serving clinical and research laboratories across Europe, Latin America, and the Middle East through a network of regional distribution partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHamburg, Germany
HQ citystring
Hamburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics, PCR test kits, infectious disease testing, nucleic acid extraction, in vitro diagnostics
Industry5 codes
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAHAOAI
Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
NAICS code3 codes
  • Medical and Diagnostic Laboratories62151
  • Medical Laboratories621511
  • Analytical Laboratory Instrument Manufacturing334516
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
  • Services-Medical Laboratories8071
Product category
Molecular Diagnostics / In Vitro Diagnostics
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1PCR Diagnostic Kit Sales
TypeHardware Sales
Description

ANCHOR Diagnostics generates revenue primarily through the sale of its molecular diagnostic PCR kits, including both CE-IVD (in vitro diagnostic) and RUO (research use only) products. Kits are sold in reaction sizes (e.g., 100 reactions per kit) and include master mix vials, positive and negative controls.

anchor-diagnostics.com
2Contract Development Services
TypeOne Time License
Description

The company offers contract development services for molecular diagnostics, including new diagnostic solution development, optimization or evaluation of existing products, and quality control and production support, providing tailored solutions to partners and customers.

anchor-diagnostics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details1 tier
1Standard reaction-based pricing for ANCHOR PCR kits (100-reaction kit format)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

PCR kits are sold in standard pack sizes (e.g., 100 reactions per kit) with pricing determined per reaction unit. Specific unit pricing is quote-based and not publicly disclosed.

anchor-diagnostics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1ANCHOR BEAD 32
Description

Sample purification product for nucleic acid extraction workflow

anchor-diagnostics.com
+4 more records
Core offering1 text field

ANCHOR Diagnostics designs, produces, and distributes high-speed molecular PCR diagnostic test systems for infectious disease detection. The portfolio combines ANCHOR BEAD 32 and SpeedPURE reagents for rapid nucleic acid extraction with a broad suite of CE-IVD and RUO ANCHOR PCR Kits covering pathogens such as CMV, EBV, HSV, VZV, BK/JC, Norovirus, C. difficile, Monkey-/Orthopoxvirus, Influenza, SARS-CoV-2, and OROV, delivering PCR results in as fast as 30 minutes. The company also offers tailored contract development services for molecular diagnostic partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Complete molecular workflow (extraction to result) in under 60 minutes, with PCR run times as fast as 30 minutes
+3 more records
Product overview1 text field

ANCHOR Diagnostics offers a unified molecular diagnostics portfolio centered on high-speed PCR technology delivering results in under 60 minutes including nucleic acid extraction and PCR. The product ecosystem combines the ANCHOR BEAD 32 and SpeedPURE Reagents for rapid sample purification, paired with an extensive suite of ANCHOR PCR Kits covering infectious disease targets including herpesviruses (CMV, EBV, HSV 1/2, VZV, HHV-6/7/8), polyomaviruses (BK/JC), respiratory pathogens (Influenza A/B, SARS-CoV-2, Viral Respiratory panel), gastrointestinal pathogens (Norovirus, C. difficile), emerging arboviruses (OROV), and orthopoxviruses. Most products are CE-IVD marked for clinical diagnostic use, with some available as Research Use Only (RUO). The company also provides contract development services for custom molecular diagnostic solutions. All products are designed for compatibility with standard laboratory workflows and real-time PCR platforms.

Product and service17 records
1ANCHOR BEAD 32
CategorySample Purification
Description

Sample purification system for rapid nucleic acid extraction, designed as part of the under-60-minute molecular workflow to enable high-speed processing for molecular diagnostics in clinical and research laboratories.

2SpeedPURE Reagents
CategorySample Purification
Description

Reagent system for rapid nucleic acid purification designed to integrate with the ANCHOR BEAD 32 sample purification workflow for streamlined molecular diagnostics.

3ANCHOR CMV PCR Kit
CategoryPCR Kit (CE-IVD)
Description

Quantitative or qualitative real-time PCR kit (CE-IVD) for amplification, detection, and quantitation of Cytomegalovirus (CMV) DNA from human EDTA plasma specimens, with a PCR run time of 30 minutes and dual-channel detection.

4ANCHOR EBV PCR Kit
CategoryPCR Kit
Description

Real-time PCR-based test for detection of Epstein-Barr Virus (EBV) DNA from clinical specimens for use in clinical and research laboratories.

5ANCHOR HSV 1/2 PCR Kit
CategoryPCR Kit
Description

Real-time PCR-based test for detection and differentiation of Herpes Simplex Virus types 1 and 2 (HSV 1/2) from clinical specimens.

6ANCHOR VZV PCR Kit
CategoryPCR Kit
Description

Real-time PCR-based test for detection of Varicella-Zoster Virus (VZV) DNA from clinical specimens.

7ANCHOR HHV-6/7/8 Multiplex PCR Kit
CategoryMultiplex PCR Kit
Description

Multiplex real-time PCR assay for simultaneous detection of Human Herpesvirus types 6, 7, and 8 from clinical specimens.

8ANCHOR BK/JC Virus PCR Kit
CategoryPCR Kit
Description

Real-time PCR-based test for detection of BK virus and JC virus DNA from clinical specimens.

9ANCHOR Viral Respiratory Multiplex PCR Kit
CategoryMultiplex PCR Kit
Description

Multiplex real-time PCR assay for simultaneous detection of multiple respiratory viruses from clinical specimens.

10ANCHOR Inf A/B + SARS-2 PCR Kit
CategoryMultiplex PCR Kit
Description

Multiplex real-time PCR assay for simultaneous detection of Influenza A, Influenza B, and SARS-CoV-2 from clinical specimens.

11ANCHOR Influenza A/B PCR Kit
CategoryPCR Kit
Description

Real-time PCR-based test for detection and differentiation of Influenza A and Influenza B viruses from clinical specimens.

12ANCHOR SARS-CoV-2 PCR Kit v 2.0
CategoryPCR Kit
Description

Real-time PCR assay for detection of SARS-CoV-2 (COVID-19) viral RNA from clinical specimens, version 2.0 formulation.

13ANCHOR Norovirus PCR Kit
CategoryPCR Kit (CE-IVD)
Description

Real-time PCR-based test (CE-IVD) for precise amplification, detection, and differentiation of Norovirus genogroup I (GI) and genogroup II (GII) RNA with internal control across three detector channels.

14ANCHOR C. difficile PCR Kit
CategoryPCR Kit (CE-IVD)
Description

Real-time PCR-based test (CE-IVD) for precise amplification and detection of toxigenic Clostridioides difficile DNA, specifically detecting Toxin A (tcdA) and Toxin B (tcdB) genes without differentiation, across two detector channels.

15ANCHOR Monkey-/Orthopoxvirus PCR Kit
CategoryPCR Kit (RUO)
Description

Real-time PCR-based test (RUO) for amplification, detection, and differentiation of Monkeypox virus DNA and other Orthopoxvirus genus members including Modified-Vaccinia-Ankara (MVA) vaccine strain, supporting clade I and II strain detection across three detector channels.

16ANCHOR OROV PCR Kit
CategoryPCR Kit (RUO)
Description

Real-time RT-PCR-based assay (RUO) for reverse transcription, amplification, and qualitative detection of Oropouche virus (OROV) RNA targeting the S-segment of the viral genome.

17Contract Development Services
CategoryContract Development Service
Description

Tailored contract development services for molecular diagnostics, including new diagnostic solution development, optimization or evaluation of existing products, quality control support, and production assistance for partners and customers.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-30
Description

ANCHOR Diagnostics expanded its Benelux region presence through Imogena, bringing rapid molecular workflows closer to laboratories across Belgium, the Netherlands, and Luxembourg. Imogena provides local distribution and technical support to clinical and research laboratories in the Benelux countries.

2SVEN Biolabs
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-19
Description

ANCHOR Diagnostics expanded its Central Europe presence through a distribution partnership with SVEN Biolabs in the Czech Republic. SVEN Biolabs provides local distribution and technical support for ANCHOR's molecular diagnostic portfolio in the Czech market, supporting the company's broader European expansion strategy.

anchor-diagnostics.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-05
Description

ANCHOR Diagnostics partnered with Sartron Biotechnology to expand molecular diagnostics access in Türkiye. Sartron Biotechnology provides local market expertise and distribution support for ANCHOR's molecular diagnostic portfolio in the Turkish market as part of the company's global expansion.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-28
Description

ANCHOR Diagnostics expanded its distribution network into Greece through a new partnership with VARELAS S.A. The partnership enables Greek laboratories to access ANCHOR's rapid molecular diagnostic solutions with local distribution and support.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-18
Description

ANCHOR Diagnostics signed a strategic distribution agreement with DSC Services, making DSC Services the official distribution partner for Colombia. DSC Services is a trusted provider of diagnostic technologies and laboratory support services in Colombia, with established relationships with clinical, research, and reference laboratories. The partnership strengthens ANCHOR's presence in Latin America and expands access to its molecular diagnostic portfolio across the region.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-27
Description

ANCHOR Diagnostics partnered with Imogena, a well-established distributor of life science and diagnostic solutions in Poland. Imogena is recognized for its strong engagement with clinical, research, and laboratory environments. This partnership enables Polish laboratories to access ANCHOR's 30-minute PCR diagnostic solutions with local technical support tailored to laboratory-specific requirements.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-20
Description

ANCHOR Diagnostics expanded into the Italian market through a partnership with Resnova, a leading provider of diagnostic and laboratory solutions in Italy. Resnova is known for its close relationships with laboratories and application-focused approach. The partnership covers Italy, San Marino, Vatican State, and the Italian-speaking part of Switzerland, providing local distribution and hands-on market support for ANCHOR's 30-minute PCR diagnostics.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-15
Description

ANCHOR Diagnostics entered a strategic distribution partnership with XboXLab to strengthen molecular diagnostics support in the Nordic region, specifically Sweden, Norway, and Finland. Founded in Sweden in 2016, XboXLab has established itself as a technically focused distributor with strong laboratory connections throughout the Nordic region. The partnership enables Nordic laboratories to access ANCHOR's rapid PCR portfolio with local technical expertise.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-10-02
Description

ANCHOR Diagnostics partnered with Max Care, a leading distributor of medical devices and equipment in Saudi Arabia, to strengthen its presence in the Middle East region. Founded in 2017, Max Care draws on more than 25 years of collective healthcare experience and operates across more than 20 countries, supporting hospitals and laboratories with access to advanced technologies.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-07-15
Description

ANCHOR Diagnostics entered into an exclusive distribution partnership with Stratech Ltd for the UK and Ireland market. Founded in 1983, Stratech is a leading provider of life science reagents and diagnostic tools with over 40 years of experience in the region. Stratech provides local distribution, logistics infrastructure, and trusted relationships with clinical, academic, and diagnostic institutions across the UK and Ireland.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

European molecular diagnostics specialist with a portfolio of PCR kits (e.g., for HSV, CMV, EBV, BK virus) targeting routine clinical and reference laboratories. Closely comparable in size, menu focus, and CE-IVD positioning.

TypeBroad incumbent
Description

Dominant clinical diagnostics player with cobas PCR systems (e.g., cobas z480 referenced in ANCHOR's cross-lab study) and a broad infectious disease menu. ANCHOR's cycler compatibility is intentionally aligned with Roche platforms, making Roche both a partner-platform and a competitive incumbent.

TypeBroad incumbent
Description

Molecular diagnostics player with the Panther system and Aptima assays for infectious disease testing. Comparable in infectious-disease menu (especially women's health and respiratory) and CE-IVD positioning.

TypeBroad incumbent
Description

Pioneer in rapid molecular diagnostics with the GeneXpert system delivering PCR results in ~30 minutes. Sets the speed benchmark ANCHOR aspires to and operates in the same hospital/lab segment.

TypeDirect peer
Description

Mid-cap IVD company specializing in molecular and immunoassay kits for infectious diseases, including PCR kits for C. difficile, respiratory, and GI pathogens. Comparable in size, product portfolio, and CE-IVD kit-led business model.

TypeBroad incumbent
Description

Major IVD company with BIOFIRE FilmArray panels and conventional PCR-based ARGENE / NucliSENS kits covering infectious diseases. Overlaps with ANCHOR's respiratory and GI PCR kits but competes primarily with integrated instrument-panel systems.

TypeBroad incumbent
Description

Global leader in sample-prep (e.g., QIAamp) and PCR-based kits (artisanal QIAstat-Dx, QuantiFERON). Overlaps with ANCHOR's BEAD 32 / SpeedPURE extraction line and PCR kit portfolio, but operates at much larger scale with FDA-cleared instruments.

TypeDirect peer
Description

Develops and commercializes a broad portfolio of CE-IVD real-time PCR kits for infectious disease diagnostics, directly overlapping with ANCHOR's herpesvirus, respiratory, and GI menus. Acquired by Siemens Healthineers, but historically a mid-cap kit-focused peer.

TypeDirect peer
Description

Korean molecular diagnostics company specializing in multiplex real-time PCR assays for infectious diseases, with a similar multiplex-channel differentiation approach. Comparable by product strategy (multiplex syndromic panels) and core technology.

TypeDirect peer
Description

Hamburg-based molecular diagnostics company of comparable size, also developing and distributing real-time PCR kits for infectious disease detection (e.g., dengue, chikungunya, SARS-CoV-2). Most direct comparable by geography, product type, and target customer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

anchor diagnostics

Molecular Diagnostics / In Vitro Diagnosticsanchor-diagnostics.com

ANCHOR Diagnostics GmbH is a Hamburg, Germany-based molecular diagnostics company developing high-speed PCR test kits and extraction reagents for infectious disease detection, serving clinical and research laboratories across Europe, Latin America, and the Middle East through a network of regional distribution partners.

What anchor diagnostics does

ANCHOR Diagnostics GmbH is a Hamburg, Germany-based molecular diagnostics company founded in 2015 that develops, manufactures, and distributes high-speed real-time PCR (polymerase chain reaction) test systems for infectious disease detection. The company's integrated workflow combines the ANCHOR BEAD 32 sample purification instrument and SpeedPURE reagents with a broad portfolio of CE-IVD-marked and RUO PCR kits covering herpesviruses (CMV, EBV, HSV 1/2, VZV, HHV-6/7/8), polyomaviruses (BK/JC), respiratory pathogens (Influenza A/B, SARS-CoV-2, viral respiratory multiplex), gastrointestinal pathogens (Norovirus, C. difficile), Monkeypox/Orthopoxvirus, and the emerging OROV arbovirus. The core technical proposition is a sub-60-minute sample-to-result workflow with PCR run times as short as 30 minutes, enabled by proprietary chemistry using distinguishable fluorescent dyes for parallel multi-target detection, integrated internal controls, and harmonized temperature profiles across all kits that allow seamless operation on standard laboratory cycler platforms (e.g., Roche MagNA Pure 96, cobas z480).

The company operates as a private GmbH with 11–50 employees and holds ISO 13485 certification for its quality management system. It generates revenue primarily through the sale of PCR kits (typically sold in 100-reaction kit formats) at quote-based unit pricing, supplemented by contract development services for custom molecular diagnostic solutions. The go-to-market model relies on a growing network of regional distribution partners across Europe (Italy, Poland, Nordics, UK & Ireland, Czech Republic, Greece, Benelux), Latin America (Colombia), the Middle East (Saudi Arabia), and Türkiye, complemented by direct quote handling via the company website and selective field sales engagement. Marketing efforts emphasize scientific credibility through LinkedIn, downloadable whitepapers, technical documentation, and participation in major industry conferences such as ESCMID.

ANCHOR Diagnostics' target customers are clinical diagnostic laboratories, research laboratories, and healthcare providers requiring rapid, reliable molecular testing for infectious disease management. The BSFZ Seal for Research and Development from the German Federal Ministry of Education and Research (awarded September 2025) and the November 2025 cross-laboratory validation study with MVZ Labor 28 (Berlin) reinforce the company's positioning on analytical rigor and scientific validation. The company is led by Thomas Grewing (legal representative) and Dr. Tobias Ruckes (Head of Sales & Marketing), with Ellen Knabbe serving as a Scientist contributing to product development. No external institutional funding rounds or acquisition activity are recorded in the available data, suggesting organic, founder-led growth.

anchor diagnostics firmographics

Firmographics
Name
anchor diagnostics
Legal name
ANCHOR Diagnostics GmbH
Website
https://anchor-diagnostics.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
ANCHOR Diagnostics GmbH is a Hamburg, Germany-based molecular diagnostics company developing high-speed PCR test kits and extraction reagents for infectious disease detection, serving clinical and research laboratories across Europe, Latin America, and the Middle East through a network of regional distribution partners.
Ownership category
akta.pro rank

anchor diagnostics industry classification

Industry
Product category
Molecular Diagnostics / In Vitro Diagnostics
NAICS
Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAHAOAI
Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)

Keywords

  • Molecular diagnostics
  • PCR test kits
  • Infectious disease testing
  • Nucleic acid extraction
  • In vitro diagnostics

Where anchor diagnostics is headquartered

Location

Headquarters

HQ city
Hamburg
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

anchor diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. PCR Diagnostic Kit Sales: ANCHOR Diagnostics generates revenue primarily through the sale of its molecular diagnostic PCR kits, including both CE-IVD (in vitro diagnostic) and RUO (research use only) products. Kits are sold in reaction sizes (e.g., 100 reactions per kit) and include master mix vials, positive and negative controls.
  2. Contract Development Services: The company offers contract development services for molecular diagnostics, including new diagnostic solution development, optimization or evaluation of existing products, and quality control and production support, providing tailored solutions to partners and customers.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard reaction-based pricing for ANCHOR PCR kits (100-reaction kit format)

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

anchor diagnostics product offering

Product offering

Core offering

ANCHOR Diagnostics designs, produces, and distributes high-speed molecular PCR diagnostic test systems for infectious disease detection. The portfolio combines ANCHOR BEAD 32 and SpeedPURE reagents for rapid nucleic acid extraction with a broad suite of CE-IVD and RUO ANCHOR PCR Kits covering pathogens such as CMV, EBV, HSV, VZV, BK/JC, Norovirus, C. difficile, Monkey-/Orthopoxvirus, Influenza, SARS-CoV-2, and OROV, delivering PCR results in as fast as 30 minutes. The company also offers tailored contract development services for molecular diagnostic partners.

Product overview

ANCHOR Diagnostics offers a unified molecular diagnostics portfolio centered on high-speed PCR technology delivering results in under 60 minutes including nucleic acid extraction and PCR. The product ecosystem combines the ANCHOR BEAD 32 and SpeedPURE Reagents for rapid sample purification, paired with an extensive suite of ANCHOR PCR Kits covering infectious disease targets including herpesviruses (CMV, EBV, HSV 1/2, VZV, HHV-6/7/8), polyomaviruses (BK/JC), respiratory pathogens (Influenza A/B, SARS-CoV-2, Viral Respiratory panel), gastrointestinal pathogens (Norovirus, C. difficile), emerging arboviruses (OROV), and orthopoxviruses. Most products are CE-IVD marked for clinical diagnostic use, with some available as Research Use Only (RUO). The company also provides contract development services for custom molecular diagnostic solutions. All products are designed for compatibility with standard laboratory workflows and real-time PCR platforms.

Differentiator

Problem solved

Functional benefit

Brands

  • ANCHOR BEAD 32: Sample purification product for nucleic acid extraction workflow
  • SpeedPURE
  • ANCHOR PCR Kits
  • ANCHOR OROV PCR Kit
  • ANCHOR CMV PCR Kit

Products and services

  • ANCHOR BEAD 32 Sample purification system for rapid nucleic acid extraction, designed as part of the under-60-minute molecular workflow to enable high-speed processing for molecular diagnostics in clinical and research laboratories.
  • SpeedPURE Reagents Reagent system for rapid nucleic acid purification designed to integrate with the ANCHOR BEAD 32 sample purification workflow for streamlined molecular diagnostics.
  • ANCHOR CMV PCR Kit Quantitative or qualitative real-time PCR kit (CE-IVD) for amplification, detection, and quantitation of Cytomegalovirus (CMV) DNA from human EDTA plasma specimens, with a PCR run time of 30 minutes and dual-channel detection.
  • ANCHOR EBV PCR Kit Real-time PCR-based test for detection of Epstein-Barr Virus (EBV) DNA from clinical specimens for use in clinical and research laboratories.
  • ANCHOR HSV 1/2 PCR Kit Real-time PCR-based test for detection and differentiation of Herpes Simplex Virus types 1 and 2 (HSV 1/2) from clinical specimens.
  • ANCHOR VZV PCR Kit Real-time PCR-based test for detection of Varicella-Zoster Virus (VZV) DNA from clinical specimens.
  • ANCHOR HHV-6/7/8 Multiplex PCR Kit Multiplex real-time PCR assay for simultaneous detection of Human Herpesvirus types 6, 7, and 8 from clinical specimens.
  • ANCHOR BK/JC Virus PCR Kit Real-time PCR-based test for detection of BK virus and JC virus DNA from clinical specimens.
  • ANCHOR Viral Respiratory Multiplex PCR Kit Multiplex real-time PCR assay for simultaneous detection of multiple respiratory viruses from clinical specimens.
  • ANCHOR Inf A/B + SARS-2 PCR Kit Multiplex real-time PCR assay for simultaneous detection of Influenza A, Influenza B, and SARS-CoV-2 from clinical specimens.
  • ANCHOR Influenza A/B PCR Kit Real-time PCR-based test for detection and differentiation of Influenza A and Influenza B viruses from clinical specimens.
  • ANCHOR SARS-CoV-2 PCR Kit v 2.0 Real-time PCR assay for detection of SARS-CoV-2 (COVID-19) viral RNA from clinical specimens, version 2.0 formulation.
  • ANCHOR Norovirus PCR Kit Real-time PCR-based test (CE-IVD) for precise amplification, detection, and differentiation of Norovirus genogroup I (GI) and genogroup II (GII) RNA with internal control across three detector channels.
  • ANCHOR C. difficile PCR Kit Real-time PCR-based test (CE-IVD) for precise amplification and detection of toxigenic Clostridioides difficile DNA, specifically detecting Toxin A (tcdA) and Toxin B (tcdB) genes without differentiation, across two detector channels.
  • ANCHOR Monkey-/Orthopoxvirus PCR Kit Real-time PCR-based test (RUO) for amplification, detection, and differentiation of Monkeypox virus DNA and other Orthopoxvirus genus members including Modified-Vaccinia-Ankara (MVA) vaccine strain, supporting clade I and II strain detection across three detector channels.
  • ANCHOR OROV PCR Kit Real-time RT-PCR-based assay (RUO) for reverse transcription, amplification, and qualitative detection of Oropouche virus (OROV) RNA targeting the S-segment of the viral genome.
  • Contract Development Services Tailored contract development services for molecular diagnostics, including new diagnostic solution development, optimization or evaluation of existing products, quality control support, and production assistance for partners and customers.

Quantifiable outcome

  • Complete molecular workflow (extraction to result) in under 60 minutes, with PCR run times as fast as 30 minutes
  • +3 more outcomes

Companies that use anchor diagnostics

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

anchor diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature8 records

anchor diagnostics partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core.

  • ImogenacoreChannel Partner/ Reseller/ Distributor · 30 June 2026ANCHOR Diagnostics expanded its Benelux region presence through Imogena, bringing rapid molecular workflows closer to laboratories across Belgium, the Netherlands, and Luxembourg. Imogena provides local distribution and technical support to clinical and research laboratories in the Benelux countries.
  • SVEN BiolabscoreChannel Partner/ Reseller/ Distributor · 19 May 2026ANCHOR Diagnostics expanded its Central Europe presence through a distribution partnership with SVEN Biolabs in the Czech Republic. SVEN Biolabs provides local distribution and technical support for ANCHOR's molecular diagnostic portfolio in the Czech market, supporting the company's broader European expansion strategy.
  • Sartron BiotechnologycoreChannel Partner/ Reseller/ Distributor · 5 May 2026ANCHOR Diagnostics partnered with Sartron Biotechnology to expand molecular diagnostics access in Türkiye. Sartron Biotechnology provides local market expertise and distribution support for ANCHOR's molecular diagnostic portfolio in the Turkish market as part of the company's global expansion.
  • VARELAS S.A.coreChannel Partner/ Reseller/ Distributor · 28 April 2026ANCHOR Diagnostics expanded its distribution network into Greece through a new partnership with VARELAS S.A. The partnership enables Greek laboratories to access ANCHOR's rapid molecular diagnostic solutions with local distribution and support.
  • DSC ServicescoreChannel Partner/ Reseller/ Distributor · 18 February 2026ANCHOR Diagnostics signed a strategic distribution agreement with DSC Services, making DSC Services the official distribution partner for Colombia. DSC Services is a trusted provider of diagnostic technologies and laboratory support services in Colombia, with established relationships with clinical, research, and reference laboratories. The partnership strengthens ANCHOR's presence in Latin America and expands access to its molecular diagnostic portfolio across the region.
  • ImogenacoreChannel Partner/ Reseller/ Distributor · 27 January 2026ANCHOR Diagnostics partnered with Imogena, a well-established distributor of life science and diagnostic solutions in Poland. Imogena is recognized for its strong engagement with clinical, research, and laboratory environments. This partnership enables Polish laboratories to access ANCHOR's 30-minute PCR diagnostic solutions with local technical support tailored to laboratory-specific requirements.
  • ResnovacoreChannel Partner/ Reseller/ Distributor · 20 January 2026ANCHOR Diagnostics expanded into the Italian market through a partnership with Resnova, a leading provider of diagnostic and laboratory solutions in Italy. Resnova is known for its close relationships with laboratories and application-focused approach. The partnership covers Italy, San Marino, Vatican State, and the Italian-speaking part of Switzerland, providing local distribution and hands-on market support for ANCHOR's 30-minute PCR diagnostics.
  • XboXLabcoreChannel Partner/ Reseller/ Distributor · 15 January 2026ANCHOR Diagnostics entered a strategic distribution partnership with XboXLab to strengthen molecular diagnostics support in the Nordic region, specifically Sweden, Norway, and Finland. Founded in Sweden in 2016, XboXLab has established itself as a technically focused distributor with strong laboratory connections throughout the Nordic region. The partnership enables Nordic laboratories to access ANCHOR's rapid PCR portfolio with local technical expertise.
  • Max CarecoreChannel Partner/ Reseller/ Distributor · 2 October 2025ANCHOR Diagnostics partnered with Max Care, a leading distributor of medical devices and equipment in Saudi Arabia, to strengthen its presence in the Middle East region. Founded in 2017, Max Care draws on more than 25 years of collective healthcare experience and operates across more than 20 countries, supporting hospitals and laboratories with access to advanced technologies.
  • Stratech LtdcoreChannel Partner/ Reseller/ Distributor · 15 July 2025ANCHOR Diagnostics entered into an exclusive distribution partnership with Stratech Ltd for the UK and Ireland market. Founded in 1983, Stratech is a leading provider of life science reagents and diagnostic tools with over 40 years of experience in the region. Stratech provides local distribution, logistics infrastructure, and trusted relationships with clinical, academic, and diagnostic institutions across the UK and Ireland.

Scale indicators5 records

Recent moves3 records

anchor diagnostics competitors and assessment

Company assessment

Direct peers

  • ELITechGroup: European molecular diagnostics specialist with a portfolio of PCR kits (e.g., for HSV, CMV, EBV, BK virus) targeting routine clinical and reference laboratories. Closely comparable in size, menu focus, and CE-IVD positioning.
  • Meridian Bioscience: Mid-cap IVD company specializing in molecular and immunoassay kits for infectious diseases, including PCR kits for C. difficile, respiratory, and GI pathogens. Comparable in size, product portfolio, and CE-IVD kit-led business model.
  • Fast Track Diagnostics (Siemens Healthineers): Develops and commercializes a broad portfolio of CE-IVD real-time PCR kits for infectious disease diagnostics, directly overlapping with ANCHOR's herpesvirus, respiratory, and GI menus. Acquired by Siemens Healthineers, but historically a mid-cap kit-focused peer.
  • Seegene: Korean molecular diagnostics company specializing in multiplex real-time PCR assays for infectious diseases, with a similar multiplex-channel differentiation approach. Comparable by product strategy (multiplex syndromic panels) and core technology.
  • Altona Diagnostics: Hamburg-based molecular diagnostics company of comparable size, also developing and distributing real-time PCR kits for infectious disease detection (e.g., dengue, chikungunya, SARS-CoV-2). Most direct comparable by geography, product type, and target customer.

Broad incumbents

  • Roche Diagnostics: Dominant clinical diagnostics player with cobas PCR systems (e.g., cobas z480 referenced in ANCHOR's cross-lab study) and a broad infectious disease menu. ANCHOR's cycler compatibility is intentionally aligned with Roche platforms, making Roche both a partner-platform and a competitive incumbent.
  • Hologic: Molecular diagnostics player with the Panther system and Aptima assays for infectious disease testing. Comparable in infectious-disease menu (especially women's health and respiratory) and CE-IVD positioning.
  • Cepheid (Danaher): Pioneer in rapid molecular diagnostics with the GeneXpert system delivering PCR results in ~30 minutes. Sets the speed benchmark ANCHOR aspires to and operates in the same hospital/lab segment.
  • bioMérieux: Major IVD company with BIOFIRE FilmArray panels and conventional PCR-based ARGENE / NucliSENS kits covering infectious diseases. Overlaps with ANCHOR's respiratory and GI PCR kits but competes primarily with integrated instrument-panel systems.
  • Qiagen: Global leader in sample-prep (e.g., QIAamp) and PCR-based kits (artisanal QIAstat-Dx, QuantiFERON). Overlaps with ANCHOR's BEAD 32 / SpeedPURE extraction line and PCR kit portfolio, but operates at much larger scale with FDA-cleared instruments.

Market position

Strengths5 records

Weaknesses5 records

Key risks7 records

Key highlights7 records

Customer concentration

anchor diagnostics social profiles

Digital presence

anchor diagnostics compliance and trust

Trust signal

Compliance2 records

anchor diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

anchor diagnostics leadership team

Management profile

Number of profiles

Profiles3 records

anchor diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

anchor diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about anchor diagnostics

What does anchor diagnostics do?

ANCHOR Diagnostics designs, produces, and distributes high-speed molecular PCR diagnostic test systems for infectious disease detection. The portfolio combines ANCHOR BEAD 32 and SpeedPURE reagents for rapid nucleic acid extraction with a broad suite of CE-IVD and RUO ANCHOR PCR Kits covering pathogens such as CMV, EBV, HSV, VZV, BK/JC, Norovirus, C. difficile, Monkey-/Orthopoxvirus, Influenza, SARS-CoV-2, and OROV, delivering PCR results in as fast as 30 minutes. The company also offers tailored contract development services for molecular diagnostic partners.

Is anchor diagnostics a public or private company?

anchor diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was anchor diagnostics founded?

anchor diagnostics was founded in 2015. It employs 11 to 50 people.

Where is anchor diagnostics based?

anchor diagnostics is headquartered in Hamburg, Germany, in the Europe region.

How does anchor diagnostics make money?

Two revenue lines are on record. PCR Diagnostic Kit Sales are the primary driver. The others are contract Development Services.

Who are anchor diagnostics's main competitors?

Direct peers on record are ELITechGroup, Meridian Bioscience, Fast Track Diagnostics (Siemens Healthineers), Seegene and Altona Diagnostics. Broad incumbents are Roche Diagnostics, Hologic, Cepheid (Danaher), bioMérieux and Qiagen.

Does anchor diagnostics have an API?

No public API is recorded for anchor diagnostics.

What industry is anchor diagnostics in?

anchor diagnostics's product category is Molecular Diagnostics / In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 62151 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales